1. Home
  2. MBBC vs CASI Comparison

MBBC vs CASI Comparison

Compare MBBC & CASI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MBBC
  • CASI
  • Stock Information
  • Founded
  • MBBC 1902
  • CASI 1991
  • Country
  • MBBC United States
  • CASI China
  • Employees
  • MBBC N/A
  • CASI N/A
  • Industry
  • MBBC Banks
  • CASI Biotechnology: Pharmaceutical Preparations
  • Sector
  • MBBC Finance
  • CASI Health Care
  • Exchange
  • MBBC Nasdaq
  • CASI Nasdaq
  • Market Cap
  • MBBC 30.4M
  • CASI 35.8M
  • IPO Year
  • MBBC N/A
  • CASI 1996
  • Fundamental
  • Price
  • MBBC $10.31
  • CASI $2.39
  • Analyst Decision
  • MBBC
  • CASI Strong Buy
  • Analyst Count
  • MBBC 0
  • CASI 1
  • Target Price
  • MBBC N/A
  • CASI $4.00
  • AVG Volume (30 Days)
  • MBBC 3.2K
  • CASI 411.7K
  • Earning Date
  • MBBC 09-24-2025
  • CASI 08-29-2025
  • Dividend Yield
  • MBBC N/A
  • CASI N/A
  • EPS Growth
  • MBBC 103.56
  • CASI N/A
  • EPS
  • MBBC 0.22
  • CASI N/A
  • Revenue
  • MBBC $6,591,743.00
  • CASI $31,564,000.00
  • Revenue This Year
  • MBBC N/A
  • CASI N/A
  • Revenue Next Year
  • MBBC N/A
  • CASI N/A
  • P/E Ratio
  • MBBC $47.09
  • CASI N/A
  • Revenue Growth
  • MBBC N/A
  • CASI 36.64
  • 52 Week Low
  • MBBC $6.38
  • CASI $1.09
  • 52 Week High
  • MBBC $12.00
  • CASI $7.67
  • Technical
  • Relative Strength Index (RSI)
  • MBBC N/A
  • CASI 60.66
  • Support Level
  • MBBC N/A
  • CASI $2.18
  • Resistance Level
  • MBBC N/A
  • CASI $2.50
  • Average True Range (ATR)
  • MBBC 0.00
  • CASI 0.24
  • MACD
  • MBBC 0.00
  • CASI -0.02
  • Stochastic Oscillator
  • MBBC 0.00
  • CASI 68.75

About MBBC Marathon Bancorp Inc. Common Stock

Marathon Bancorp Inc is a Wisconsin-chartered savings bank. It is a community-oriented bank offering a variety of financial products and services to meet the needs of customers. The primary deposit products are demand deposits, savings, and certificates of deposits; and prime lending products are commercial real estate, commercial and industrial, construction, one-to-four-family residential, multifamily real estate, and consumer loans. The majority of the Company's revenues come from interest income on loans and debt securities.

About CASI CASI Pharmaceuticals Inc.

CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.

Share on Social Networks: